Article Versions Notes

Shoaib S, Ansari MA, Fatease AA, Safhi AY, Hani U, Jahan R, Alomary MN, Ansari MN, Ahmed N, Wahab S, et al. Plant-Derived Bioactive Compounds in the Management of Neurodegenerative Disorders: Challenges, Future Directions and Molecular Mechanisms Involved in Neuroprotection. Pharmaceutics. 2023; 15(3):749. https://doi.org/10.3390/pharmaceutics15030749

Shoaib, Shoaib, Mohammad Azam Ansari, Adel Al Fatease, Awaji Y. Safhi, Umme Hani, Roshan Jahan, Mohammad N. Alomary, Mohd Nazam Ansari, Nabeel Ahmed, Shadma Wahab, and et al. 2023. "Plant-Derived Bioactive Compounds in the Management of Neurodegenerative Disorders: Challenges, Future Directions and Molecular Mechanisms Involved in Neuroprotection" Pharmaceutics 15, no. 3: 749. https://doi.org/10.3390/pharmaceutics15030749

Shoaib, S., Ansari, M. A., Fatease, A. A., Safhi, A. Y., Hani, U., Jahan, R., Alomary, M. N., Ansari, M. N., Ahmed, N., Wahab, S., Ahmad, W., Yusuf, N., & Islam, N. (2023). Plant-Derived Bioactive Compounds in the Management of Neurodegenerative Disorders: Challenges, Future Directions and Molecular Mechanisms Involved in Neuroprotection. Pharmaceutics, 15(3), 749. https://doi.org/10.3390/pharmaceutics15030749